Recombinant Citrobacter koseri Probable ubiquinone biosynthesis protein UbiB (ubiB) is a recombinant protein derived from the bacterium Citrobacter koseri. This protein is involved in the biosynthesis of ubiquinone, a crucial component in the electron transport chain of bacteria. The UbiB protein plays a significant role in the synthesis pathway of ubiquinone, which is essential for bacterial energy production and survival.
The UbiB protein is part of the ubiquinone biosynthesis pathway, which involves several enzymes working together to produce ubiquinone. Ubiquinone is vital for the transfer of electrons during oxidative phosphorylation, allowing bacteria to generate ATP efficiently. In Citrobacter koseri, this protein is encoded by the ubiB gene and is crucial for maintaining the bacterium's energy metabolism.
Source: The recombinant UbiB protein is derived from Citrobacter koseri, specifically from strains like ATCC BAA-895 / CDC 4225-83 / SGSC4696.
Sequence Information: The protein sequence is available, with a length of 546 amino acids, and its Uniprot accession number is A8ACY4.
Storage and Handling: The recombinant protein is typically stored in a Tris-based buffer with 50% glycerol at -20°C to maintain stability. Repeated freezing and thawing should be avoided.
Applications: This protein can be used in various biochemical assays, such as ELISA, to study ubiquinone biosynthesis or for research into Citrobacter koseri pathogenicity.
| Characteristic | Description |
|---|---|
| Source | Citrobacter koseri (e.g., ATCC BAA-895) |
| Gene Name | ubiB |
| Protein Length | 546 amino acids |
| Uniprot Accession | A8ACY4 |
| Storage Conditions | -20°C in Tris-based buffer with 50% glycerol |
| Applications | Biochemical assays, ELISA |
KEGG: cko:CKO_00178
STRING: 290338.CKO_00178
UbiB in C. koseri functions as an essential component in the oxygen-dependent pathway for ubiquinone (UQ) biosynthesis. The protein demonstrates ATPase activity and is specifically required for aerobic conditions of growth. When examining the metabolic pathway, UbiB participates in the hydroxylation reactions needed to modify the aromatic ring of 4-hydroxybenzoic acid (4-HB) during UQ synthesis .
Research methodologically demonstrates this role through knockout studies, where ΔubiB strains produce significantly reduced amounts of ubiquinone (UQ8) specifically under aerobic conditions . The experimental approach to confirm UbiB function typically involves:
Generation of targeted gene deletions using λ-Red recombination
Complementation studies with plasmid-expressed ubiB
HPLC quantification of ubiquinone levels under varying oxygen conditions
Assessment of growth rates in defined media with differential carbon sources
For optimal expression and purification of recombinant C. koseri UbiB, researchers should employ the following methodological approach:
Cloning the ubiB gene with appropriate tags (typically N-terminal His6 or Strep-tag)
Expression in E. coli BL21(DE3) or similar strain using an inducible system (IPTG-inducible T7 promoter)
Growth at lower temperatures (16-20°C) after induction to enhance protein solubility
Cell lysis under anaerobic conditions to maintain native protein structure
Purification using affinity chromatography followed by size exclusion
Critical consideration must be given to buffer composition, as the ATPase activity of UbiB requires specific conditions:
pH maintained at 7.5-8.0
Inclusion of magnesium (1-5 mM MgCl₂)
Addition of reducing agents (1-5 mM DTT or TCEP)
Potential addition of ubiquinone precursors for stability
The purified protein can then be assessed for ATPase activity using malachite green phosphate detection assays or radioactive ATP hydrolysis assays.
To effectively study C. koseri UbiB function, researchers should consider complementary experimental systems:
In vivo systems:
C. koseri ubiB knockout strains complemented with wild-type or mutant ubiB variants
E. coli ubiB mutants complemented with C. koseri ubiB for comparative studies
Growth under varying oxygen concentrations (aerobic, microaerobic, anaerobic)
Infection models in appropriate animals (neonatal rat and mouse models)
In vitro systems:
Reconstituted ubiquinone biosynthesis assays with purified components
ATPase activity measurements with varying substrates
Protein-protein interaction studies with other ubiquinone biosynthesis components
Membrane association assays to determine subcellular localization
Analytical approaches:
LC-MS/MS for identification of reaction intermediates
HPLC for quantification of ubiquinone and precursors
RNA-seq for transcriptional analysis under varying conditions
Protein co-immunoprecipitation to identify interaction partners
The combination of these systems provides comprehensive insights into UbiB function and regulation within the broader context of ubiquinone biosynthesis.
The function of UbiB shows striking pathway-specific activity in C. koseri ubiquinone biosynthesis. UbiB operates exclusively in the oxygen-dependent pathway, as demonstrated by the observation that ΔubiB strains produce limited ubiquinone only under aerobic conditions . In contrast, under anaerobic conditions, C. koseri employs an alternative O₂-independent pathway for ubiquinone biosynthesis that does not require UbiB.
Methodologically, this differential function can be investigated through:
Metabolomic profiling of ubiquinone intermediates in wild-type vs. ΔubiB strains under varying O₂ conditions
Isotope labeling studies using ¹³C-labeled precursors to track carbon flow through different pathways
Comparative transcriptomics and proteomics of cells grown under aerobic vs. anaerobic conditions
In vitro reconstitution of both pathways with purified components
Research findings indicate that while the O₂-dependent pathway utilizes UbiB for hydroxylation reactions, the O₂-independent pathway employs alternative hydroxylases (UbiU-UbiV) that utilize [4Fe-4S] clusters to catalyze similar reactions without molecular oxygen . This represents a remarkable example of metabolic plasticity that allows proteobacteria like C. koseri to synthesize ubiquinone across the entire range of environmental oxygen levels.
| Pathway Component | O₂-dependent (Aerobic) | O₂-independent (Anaerobic) |
|---|---|---|
| Initial enzymes (UbiA) | Required | Required |
| UbiB | Required | Not required |
| UbiJ/UbiK | Required | Not required |
| UbiU/UbiV | Not required | Required |
| Terminal enzymes (UbiE, UbiG) | Required | Required |
| Oxygen requirement | Molecular O₂ as substrate | No O₂ required |
| Iron-sulfur clusters | Not used | [4Fe-4S] in UbiU/UbiV |
C. koseri UbiB contains several crucial domains that define its function in ubiquinone biosynthesis:
N-terminal nucleotide-binding domain: Contains the Walker A and Walker B motifs essential for ATP binding and hydrolysis
C-terminal α-helical domain: Likely involved in protein-protein interactions with other ubiquinone biosynthesis enzymes
Conserved LYK motif: Critical for catalytic activity, potentially involved in substrate recognition
Membrane-association motifs: Hydrophobic patches that facilitate association with the inner membrane where ubiquinone synthesis occurs
Methodological approaches to investigate domain functionality include:
Site-directed mutagenesis of key residues followed by complementation assays
Truncation analysis to define minimal functional domains
Domain-swapping experiments with homologous proteins from other species
Hydrogen-deuterium exchange mass spectrometry to identify substrate-binding regions
Crystallography or cryo-EM structural studies combined with molecular dynamics simulations
Functional analysis should employ activity assays measuring:
ATP hydrolysis rates with purified protein
Binding affinity for ubiquinone precursors
Protein-protein interaction strength with other pathway components
In vivo complementation efficiency of mutant variants
Research indicates that mutations in the Walker A motif (particularly the lysine residue) abolish ATPase activity and consequently ubiquinone biosynthesis, suggesting that ATP hydrolysis is coupled to the catalytic function of UbiB in the hydroxylation reactions of the ubiquinone pathway.
The relationship between UbiB expression and C. koseri virulence presents an intriguing area of research. While not directly identified as a classical virulence factor, UbiB's role in ubiquinone biosynthesis indirectly affects bacterial pathogenicity through modulation of energy metabolism and stress responses.
Methodological approaches to investigate this relationship include:
Infection models with UbiB variants:
Virulence assays:
Survival within macrophages and brain microvascular endothelial cells
Biofilm formation capability
Resistance to oxidative and nitrosative stress
Growth in iron-limited conditions
Transcriptional analysis:
RNA-seq comparing expression profiles of wild-type and ΔubiB strains during infection
ChIP-seq to identify regulators of ubiB expression under different conditions
qRT-PCR validation of key virulence genes
Research findings suggest that UbiB-dependent ubiquinone biosynthesis may be particularly important during certain phases of infection. Since C. koseri can cause meningitis and brain abscess in neonates and immunocompromised individuals , the ability to synthesize ubiquinone under varying oxygen tensions within host tissues is likely critical for sustained virulence. The brain environment, in particular, may present unique oxygen gradients that require metabolic flexibility.
The impact of UbiB on virulence should be considered alongside other identified C. koseri virulence factors, including those involved in flagellar apparatus biosynthesis (ompA, csg fimbriae, and the che operon) and iron uptake systems (chu, fep, and ent) .
While direct evidence for interaction between UbiB and the high-pathogenicity island (HPI) in C. koseri is limited, integrative analysis suggests potential functional relationships worthy of investigation.
The HPI cluster in C. koseri has been identified as a key virulence determinant, with deletion mutants showing significantly decreased virulence in animal models . This cluster is involved in iron acquisition, which is essential for bacterial pathogenesis. Ubiquinone biosynthesis and iron metabolism are interconnected through several mechanisms:
Respiratory chain function: Ubiquinone-dependent respiration requires iron-containing proteins
Oxidative stress resistance: Both systems contribute to managing oxidative stress
Energy provision for iron transport: ATP generated via ubiquinone-dependent respiration powers iron acquisition systems
Methodological approaches to investigate this relationship include:
Construction of double mutants (ΔubiB/ΔHPI) to assess synergistic effects
Transcriptional analysis of iron uptake genes in ΔubiB strains
Measurement of intracellular iron levels in various mutant backgrounds
Assessment of ubiquinone levels in HPI mutants
Animal studies have demonstrated that HPI deletion severely attenuates C. koseri virulence in vivo, with mutants losing the ability to replicate in the brain . Similar studies with UbiB mutants could reveal whether ubiquinone biosynthesis defects result in comparable attenuation, potentially suggesting a functional link between these systems.
| Parameter | Wild-type C. koseri | ΔHPI Mutant | Potential ΔubiB Phenotype |
|---|---|---|---|
| Brain Colonization | High | Severely reduced | Likely reduced under aerobic conditions |
| Blood Survival | High | Moderately reduced | Likely strain context-dependent |
| Survival Time in Animal Models | 36h (rats), 144h (mice) | 84h (rats), survived (mice) | Predicted intermediate phenotype |
| Iron Acquisition | Efficient | Compromised | Indirectly affected |
| Respiratory Capacity | Full | Potentially compromised | Reduced under aerobic conditions |
The regulation of UbiB in response to environmental oxygen levels represents a sophisticated example of bacterial adaptation. Given that UbiB functions specifically in the O₂-dependent pathway for ubiquinone biosynthesis, its expression and activity must be precisely coordinated with oxygen availability.
Methodological approaches to investigate oxygen-dependent regulation include:
Transcriptional analysis:
Promoter mapping using 5' RACE
Reporter fusion assays (lacZ, gfp) to monitor promoter activity
ChIP-seq to identify transcription factors binding the ubiB promoter
RNA-seq comparing expression under aerobic, microaerobic, and anaerobic conditions
Protein-level regulation:
Western blotting to quantify UbiB levels under different oxygen tensions
Pulse-chase experiments to determine protein stability
Post-translational modification analysis using mass spectrometry
Protein-protein interaction screens to identify regulatory partners
Functional assays:
Measurement of ATPase activity under different redox conditions
Assessment of membrane association as a function of oxygen availability
Determination of ubiquinone synthesis rates during oxygen transitions
Research findings suggest that bacteria equipped with both O₂-dependent and O₂-independent pathways, like C. koseri, have evolved sophisticated regulatory mechanisms to seamlessly transition between these pathways . This metabolic plasticity likely involves multiple layers of regulation, from transcriptional control to allosteric modulation of enzyme activity.
Potential oxygen-sensing mechanisms regulating UbiB may include:
FNR-like transcription factors that respond directly to oxygen
ArcAB two-component system sensing respiratory chain status
SoxRS system responding to oxidative stress
Iron-sulfur cluster-containing regulators sensitive to oxygen and iron availability